These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7933539)

  • 41. [Effects of cefdinir in pediatric infectious diseases].
    Ge YL; Zhu QR
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):233-5. PubMed ID: 15833212
    [No Abstract]   [Full Text] [Related]  

  • 42. In vitro and in vivo microbiological evaluations of cefoperazone.
    Renzini G; Ravagnan G; Piccolomini R; Dainelli B; Comanducci A
    Clin Ther; 1980; 3(Spec Issue):139-44. PubMed ID: 6446388
    [No Abstract]   [Full Text] [Related]  

  • 43. [The cephalosporins. I].
    Fossati C
    Clin Ter; 1978 Jan; 84(2):167-93. PubMed ID: 348382
    [No Abstract]   [Full Text] [Related]  

  • 44. Sequential therapy with intravenous and oral cephalosporins.
    Janknegt R; van der Meer JW
    J Antimicrob Chemother; 1994 Jan; 33(1):169-77. PubMed ID: 8157558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pharmacokinetic, bacteriological and clinical studies on cefditoren pivoxil in children].
    Tajima T; Kobayashi M; Negishi S; Nishimura S; Yoshida A; Kudo S; Gondou M; Nakayama T; Abe T
    Jpn J Antibiot; 1993 Jul; 46(7):589-95. PubMed ID: 8371494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cephazolin: bacteriological study and clinical results].
    Bertrand A; Janbon F; Despaux E; Jourdan J
    Nouv Presse Med; 1974 Apr; 3(0):28-32. PubMed ID: 4599827
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacokinetic/pharmacodynamic serum and urine profile of cefditoren following single-dose and multiple twice- and thrice-daily regimens in healthy volunteers: a phase I study.
    Sádaba B; Azanza JR; Quetglas EG; Campanero MA; Honorato J; Coronel P; Gimeno M
    Rev Esp Quimioter; 2007 Mar; 20(1):51-60. PubMed ID: 17530036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Fundamental and clinical studies on ceftazidime in the field of paediatrics].
    Nakamura T; Seto S; Kimura K; Sato K; Sato H; Fukuda F; Nishikawa S
    Jpn J Antibiot; 1984 Mar; 37(3):485-9. PubMed ID: 6376857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Reevaluation of current antimicrobials. Series 26: flomoxef].
    Ike Y; Wada K
    Jpn J Antibiot; 1995 Jan; 48(1):23-30. PubMed ID: 7699842
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical studies on S-1108 in the field pediatrics].
    Kuno K; Ogawa A; Hayakawa F; Ito K; Kondo M; Okumura A; Natsume J
    Jpn J Antibiot; 1993 Nov; 46(11):1017-24. PubMed ID: 8309064
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cefoperazone].
    Ueda Y
    Jpn J Antibiot; 1982 May; 35(5):1104-26. PubMed ID: 6215505
    [No Abstract]   [Full Text] [Related]  

  • 52. In vitro and in vivo antibacterial activity of cefoperazone.
    Mitsuhashi S; Minami S; Matsubara N; Yotsuji A; Kurashige S; Saikawa I
    Clin Ther; 1980; 3(Spec Issue):1-13. PubMed ID: 6446381
    [No Abstract]   [Full Text] [Related]  

  • 53. [Bacteriological, pharmacological and clinical study of cephazolin].
    Tancrède C; Betourné C
    Nouv Presse Med; 1974 Apr; 3(0):34-7. PubMed ID: 4600178
    [No Abstract]   [Full Text] [Related]  

  • 54. [Oral cephalosporins].
    Kees F
    Med Monatsschr Pharm; 1992 Jan; 15(1):2-10. PubMed ID: 1542277
    [No Abstract]   [Full Text] [Related]  

  • 55. Cefditoren versus ceftazidime in inducer-substrate combinations for the evaluation of AmpC production in a disc approximation test.
    Cafini F; Aguilar L; Alou L; Giménez MJ; Sevillano D; Torrico M; González N; Coronel P; Prieto J
    Rev Esp Quimioter; 2010 Jun; 23(2):72-5. PubMed ID: 20559604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Combined antimicrobial preparations].
    Ikemoto H
    Nihon Rinsho; 1990 Oct; 48(10):2218-21. PubMed ID: 2280467
    [No Abstract]   [Full Text] [Related]  

  • 57. [Cefdinir].
    Soejima R
    Jpn J Antibiot; 1992 Oct; 45(10):1239-52. PubMed ID: 1479675
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical evaluation of a new parenteral cephem, cefozopran, in children].
    Taniuchi S; Higashino H; Takaya J; Ishizaki Y; Kino M; Man W; Kobayashi Y
    Jpn J Antibiot; 1994 Nov; 47(11):1553-8. PubMed ID: 7853685
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New perspectives in oral antibiotic therapy: cefatrizine. Conclusions.
    Kuemmerle HP
    Drugs Exp Clin Res; 1985; 11(7):461. PubMed ID: 3836870
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacokinetics and pharmacodynamics of oral cephalosporins as critical factors in choice of antibiotics.
    Novelli A; Fallani S; Cassetta MI; Conti S
    Int J Antimicrob Agents; 2000 Dec; 16(4):501-5. PubMed ID: 11118868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.